Literature DB >> 26422462

Patterns of cannabis use in patients with Inflammatory Bowel Disease: A population based analysis.

Alexandra Weiss1, Frank Friedenberg2.   

Abstract

BACKGROUND: Tobacco use patterns and effects in patients with Inflammatory Bowel Disease have been extensively studied, however the role and patterns of cannabis use remains poorly defined. Our aim was to evaluate patterns of marijuana use in a large population based survey.
METHODS: Cases were identified from the NHANES database from the National Center for Health Statistics for the time period from January, 2009 through December, 2010 as having ulcerative colitis or Crohn's disease, and exact matched with controls using the Propensity Score Module of SPSS, based on age, gender, and sample weighted using the nearest neighbor method.
RESULTS: After weighting, 2084,895 subjects with IBD and 2013,901 control subjects were identified with no significant differences in demographic characteristics. Subjects with IBD had a higher incidence of ever having used marijuana/hashish (M/H) (67.3% vs. 60.0%) and an earlier age of onset of M/H use (15.7 years vs. 19.6 years). Patients with IBD were less likely to have used M/H every month for a year, but more likely to use a heavier amount per day (64.9% subjects with IBD used three or more joints per day vs. 80.5% of subjects without IBD used two or fewer joints per day). In multivariable logistic regression, presence of IBD, male gender, and age over 40 years predicted M/H use.
CONCLUSION: Our study is the first to evaluate marijuana patterns in a large-scale population based survey. Older, male IBD patients have the highest odds of marijuana use.
Copyright © 2015 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Cannabis; Inflammatory Bowel Disease; Marijuana

Mesh:

Year:  2015        PMID: 26422462     DOI: 10.1016/j.drugalcdep.2015.08.035

Source DB:  PubMed          Journal:  Drug Alcohol Depend        ISSN: 0376-8716            Impact factor:   4.492


  26 in total

Review 1.  British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults.

Authors:  Christopher Andrew Lamb; Nicholas A Kennedy; Tim Raine; Philip Anthony Hendy; Philip J Smith; Jimmy K Limdi; Bu'Hussain Hayee; Miranda C E Lomer; Gareth C Parkes; Christian Selinger; Kevin J Barrett; R Justin Davies; Cathy Bennett; Stuart Gittens; Malcolm G Dunlop; Omar Faiz; Aileen Fraser; Vikki Garrick; Paul D Johnston; Miles Parkes; Jeremy Sanderson; Helen Terry; Daniel R Gaya; Tariq H Iqbal; Stuart A Taylor; Melissa Smith; Matthew Brookes; Richard Hansen; A Barney Hawthorne
Journal:  Gut       Date:  2019-09-27       Impact factor: 23.059

2.  Low-Dose Cannabidiol Is Safe but Not Effective in the Treatment for Crohn's Disease, a Randomized Controlled Trial.

Authors:  Timna Naftali; Refael Mechulam; Amir Marii; Gila Gabay; Asaf Stein; Miriam Bronshtain; Ido Laish; Fabiana Benjaminov; Fred M Konikoff
Journal:  Dig Dis Sci       Date:  2017-03-27       Impact factor: 3.199

3.  Is Cannabis of Potential Value as a Therapeutic for Inflammatory Bowel Disease?

Authors:  Timna Naftali
Journal:  Dig Dis Sci       Date:  2019-10       Impact factor: 3.199

4.  Profiles of Patients Who Use Marijuana for Inflammatory Bowel Disease.

Authors:  Ann Marie Kerlin; Millie Long; Michael Kappelman; Christopher Martin; Robert S Sandler
Journal:  Dig Dis Sci       Date:  2018-03-29       Impact factor: 3.199

5.  Association Between Cannabis Use and Complications Related to Crohn's Disease: A Retrospective Cohort Study.

Authors:  Chimezie Mbachi; Bashar Attar; Yuchen Wang; Isaac Paintsil; Benjamin Mba; Setri Fugar; Rohit Agrawal; Roberto Carlos Simons-Linares; Palash Jaiswal; William Trick; Vikram Kotwal
Journal:  Dig Dis Sci       Date:  2019-03-02       Impact factor: 3.199

6.  Therapeutic Use of Cannabis in Inflammatory Bowel Disease.

Authors:  Waseem Ahmed; Seymour Katz
Journal:  Gastroenterol Hepatol (N Y)       Date:  2016-11

Review 7.  Integrating Endocannabinoid Signaling and Cannabinoids into the Biology and Treatment of Posttraumatic Stress Disorder.

Authors:  Matthew N Hill; Patrizia Campolongo; Rachel Yehuda; Sachin Patel
Journal:  Neuropsychopharmacology       Date:  2017-07-26       Impact factor: 7.853

8.  Preadmission Cannabis Use Is Positively Correlated With Inpatient Opioid Dose Exposure in Hospitalized Patients With Inflammatory Bowel Diseases.

Authors:  Rahul S Dalal; Sonali Palchaudhuri; Christopher K Snider; James D Lewis; Shivan J Mehta; Gary R Lichtenstein
Journal:  Inflamm Bowel Dis       Date:  2021-03-15       Impact factor: 5.325

9.  Symptoms and Extraintestinal Manifestations in Active Cannabis Users with Inflammatory Bowel Disease.

Authors:  Matthew D Coates; Shannon Dalessio; Vonn Walter; August Stuart; Nana Bernasko; Andrew Tinsley; Sanam Razeghi; Emmanuelle D Williams; Kofi Clarke; Kent Vrana
Journal:  Cannabis Cannabinoid Res       Date:  2021-03-24

10.  Inflammatory Bowel Disease and Cannabis: A Practical Approach for Clinicians.

Authors:  Megan C Buckley; Anand Kumar; Arun Swaminath
Journal:  Adv Ther       Date:  2021-06-10       Impact factor: 3.845

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.